Menu
Consolidated Income Statement
35.5 KB
EXCEL
€ million |
Note |
2016 |
2015 |
Net sales |
➞ 7 |
15,024 |
12,845 |
Cost of sales |
➞ 8 |
– 5,201 |
– 4,076 |
(of which: amortization of intangible assets)1 |
|
(– 181) |
(– 167) |
Gross profit |
|
9,823 |
8,768 |
|
|
|
|
Marketing and selling expenses |
➞ 9 |
– 4,526 |
– 4,050 |
(of which: amortization of intangible assets)1 |
|
(– 1,032) |
(– 779) |
Administration expenses |
|
– 854 |
– 720 |
Research and development costs |
➞ 10 |
– 1,976 |
– 1,709 |
(of which: amortization of intangible assets)1 |
|
(– 4) |
(– 3) |
Other operating income |
➞ 11 |
996 |
471 |
Other operating expenses |
➞ 12 |
– 981 |
– 917 |
Operating result (EBIT) |
|
2,481 |
1,843 |
|
|
|
|
Financial result |
➞ 13 |
– 326 |
– 357 |
Profit before income tax |
|
2,154 |
1,487 |
|
|
|
|
Income tax |
➞ 14 |
– 521 |
– 368 |
Profit after tax from continuing operations |
|
1,633 |
1,118 |
Profit after tax from discontinued operations |
|
– |
6 |
Profit after tax |
|
1,633 |
1,124 |
|
|
|
|
of which: attributable to Merck KGaA shareholders (net income) |
|
1,629 |
1,115 |
of which: attributable to non-controlling interests |
➞ 24 |
4 |
9 |
|
|
|
|
Earnings per share (in €) |
➞ 15 |
|
|
basic |
|
3.75 |
2.56 |
– thereof: from continuing operations |
|
3.75 |
2.55 |
– thereof: from discontinued operations |
|
– |
0.01 |
|
|
|
|
diluted |
|
3.75 |
2.56 |
– thereof: from continuing operations |
|
3.75 |
2.55 |
– thereof: from discontinued operations |
|
– |
0.01 |